Decreased plasma neuropeptides in first-episode schizophrenia, bipolar disorder, major depressive disorder: associations with clinical symptoms and cognitive function.

Hua Yu,Peiyan Ni,Liansheng Zhao,Yang Tian,Mingli Li,Xiaojing Li,Wei Wei,Jinxue Wei,Wei Deng,Xiangdong Du,Qiang Wang,Wanjun Guo,Xiaohong Ma,Jeremy Coid,Tao Li

Frontiers in psychiatry（2023）

引用 0|浏览1

暂无评分

摘要

Our research shows decreased circulating neuropeptides have the potential to differentiate severe mental illnesses from controls. These neuropeptides are promising treatment targets for improving clinical symptoms and cognitive function in FES, BD, and MDD.

查看译文

关键词

schizophrenia,bipolar disorder,major depressive disorder,neuropeptide,disease monitoring

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要